Clinical Trials Browser

Phase 1/2 × Suspended × Decitabine × Clear all

NCT04485052 2023-10-23

Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid Leukemia

Phase 1/2 Suspended

Other hematologic neoplasm

Leukemia, Myeloid, Acute